Correlation Between South American and Esperion Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both South American and Esperion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining South American and Esperion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between South American Gold and Esperion Therapeutics, you can compare the effects of market volatilities on South American and Esperion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in South American with a short position of Esperion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of South American and Esperion Therapeutics.

Diversification Opportunities for South American and Esperion Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between South and Esperion is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding South American Gold and Esperion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esperion Therapeutics and South American is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on South American Gold are associated (or correlated) with Esperion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esperion Therapeutics has no effect on the direction of South American i.e., South American and Esperion Therapeutics go up and down completely randomly.

Pair Corralation between South American and Esperion Therapeutics

Given the investment horizon of 90 days South American Gold is expected to generate 22.81 times more return on investment than Esperion Therapeutics. However, South American is 22.81 times more volatile than Esperion Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Esperion Therapeutics is currently generating about 0.08 per unit of risk. If you would invest  0.01  in South American Gold on September 3, 2024 and sell it today you would lose (0.01) from holding South American Gold or give up 100.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

South American Gold  vs.  Esperion Therapeutics

 Performance 
       Timeline  
South American Gold 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days South American Gold has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, South American is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Esperion Therapeutics 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Esperion Therapeutics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Esperion Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

South American and Esperion Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with South American and Esperion Therapeutics

The main advantage of trading using opposite South American and Esperion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if South American position performs unexpectedly, Esperion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will offset losses from the drop in Esperion Therapeutics' long position.
The idea behind South American Gold and Esperion Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals